Ambrx Financial Statements From 2010 to 2025
Ambrx Biopharma financial statements provide useful quarterly and yearly information to potential Ambrx Biopharma American investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Ambrx Biopharma financial statements helps investors assess Ambrx Biopharma's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Ambrx Biopharma's valuation are summarized below:Ambrx Biopharma American does not presently have any fundamental signals for analysis.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Check Ambrx Biopharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ambrx Biopharma's main balance sheet or income statement drivers, such as , as well as many indicators such as . Ambrx financial statements analysis is a perfect complement when working with Ambrx Biopharma Valuation or Volatility modules.
Ambrx |
Ambrx Biopharma American Company Shares Outstanding Analysis
Ambrx Biopharma's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Ambrx Biopharma Shares Outstanding | 63.29 M |
Most of Ambrx Biopharma's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ambrx Biopharma American is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, Ambrx Biopharma American has 63.29 M of shares currently outstending. This is 64.94% lower than that of the Biotechnology sector and 40.77% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 88.93% higher than that of the company.
Ambrx Biopharma American Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Ambrx Biopharma's current stock value. Our valuation model uses many indicators to compare Ambrx Biopharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ambrx Biopharma competition to find correlations between indicators driving Ambrx Biopharma's intrinsic value. More Info.Ambrx Biopharma American is rated below average in return on equity category among its peers. It is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Ambrx Biopharma by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in Ambrx Stock
If you are still planning to invest in Ambrx Biopharma American check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ambrx Biopharma's history and understand the potential risks before investing.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Commodity Directory Find actively traded commodities issued by global exchanges |